Core Viewpoint - The innovative product JAZZ fixation tension band system from Implanet has received registration approval from the National Medical Products Administration and has successfully completed surgical implants in several hospitals, enhancing the company's market competitiveness and overall strength [1] Group 1 - The JAZZ fixation tension band system is designed to complement the company's innovative full range of spinal fixation systems [1] - The approval and successful implementation of the JAZZ system provide clinical doctors with a more comprehensive and advanced treatment option for spinal surgeries [1] - This development is expected to further strengthen the company's competitive advantage in the market [1]

Core Viewpoint - Implanet's innovative product, the JAZZ® fixed tension band system, has received regulatory approval in China and has been successfully implanted in several hospitals, enhancing the company's market competitiveness and overall strength [1] Group 1: Revenue Growth and Market Potential - Implanet is projected to achieve a 33% revenue growth by 2025, with a 49% growth rate in the U.S. market [1] - The company is expected to leverage synergies from the JAZZ® product's launch in China to set revenue targets for 2026-2027 [1] Group 2: Product Development and Clinical Application - The JAZZ® system complements the company's innovative full range of spinal fixation systems, providing a more comprehensive and advanced treatment option for spinal surgeries [1] - The company encourages stakeholders to monitor its regular reports for more information on operational performance [1]